A number of the new indicators take account of patient frailty when setting standards of care, highlighting how treatment benefits must be considered alongside the risk of harm from treatment. For example, one new indicator is the percentage of patients with diabetes without moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 58mmol/mol or less in the preceding 12 months. NICE states that this indicator allows for an individualised management approach that adjusts care according to an individual’s frailty status. It aims to enable patients with little comorbidity to benefit from tighter glycaemic control whilst aiming to encourage the personalisation of care for people with moderate or severe frailty.
Cite this: Dr Rob Hicks. UK Guidelines Quiz: New NICE Primary Care Indicators for Diabetes - Medscape - Nov 05, 2018.
Comments